ESMO Examination for Medical Oncologists

2019 ESMO Examination 

The main session of the 2019 ESMO Examination will be held on Saturday 28 September 2019 (17:30-20:00) during the ESMO 2019 Congress in Barcelona, Spain. Parallel sessions will be held in Egypt, India, Iraq, Germany and Switzerland.

The 2019 Exam will be available in English, German or French. Please choose the preferred language in your registration.

Exam registration fees and deadlines

Deadline ESMO Members AIO, DGHO, FMH Members
Early registration: extended to 24 March 2019 €60.00 + VAT (if applicable) €300.00 + VAT (if applicable)
Late registration: 22 July 2019 €200.00 + VAT (if applicable) €300.00 + VAT (if applicable)
Onsite: 28th of September 2019
Only at main session in Barcelona*
€300.00 + VAT (if applicable) Only for ESMO Members

*Member Lounge, 09.00-13.00 hrs

Exam Main Session: Barcelona, Spain

The main session of the 2019 ESMO Examination will take place at Hesperia Barcelona Tower which is a different venue from the ESMO 2019 Congress venue.

Bus transfers to the Examination venue are available from the South Entrance of Fira Gran Via.
Enrolment starts at 16:00, Examination starts at 17:30.
More details: ESMO Examination 2019 Barcelona Flyer 

About the Exam

ESMO examination

The ESMO Examination is a valuable assessment tool for practising medical oncologists and an excellent opportunity for medical oncologists in training to assess their knowledge. The ESMO Examination is the written part of the Board Certification in Medical Oncology in Switzerland and Slovenia. In all other countries the ESMO Examination certifies an excellent knowledge in the field of Medical Oncology according to the criteria of the European Society for Medical Oncology.

The ESMO Examination has no legal standing since only national authorities can grant physicians the right to practice.

Successful candidates will be certified for five years. After five years recertification can be attained either by re-taking the ESMO Examination (on passing, recertification is valid for a further five years) or for ESMO members participation in the ESMO Medical Oncologist’s Recertification Approval (MORA) which is a proof of continuing medical education – allowing ESMO members to remain certified in medical oncology. If approved, the recertification is also valid for five years.

CME Points

The ESMO Examination is accredited with 50 category 1 ESMO-MORA CME points.

Examination Format

Questions cover all fields of medical oncology, including: basic elements of tumour path histology, epidemiology and biology. Besides all cancer types, the ESMO Examination includes practice-oriented issues on diagnosis, staging, management, evaluation and prognosis of cancer patients.

  • Written Examination of 150 minutes
  • 100 multiple choice questions are divided as follows:
    • 75 type A questions
    • 25 type K' questions
  • Pass score: according to the Rasch procedure, the pass score will fluctuate around 60% (empirically ± 5% than in previous years) to keep exam difficulty comparable from year to year

Preparing for the Examination

To prepare for the ESMO Examination, we recommend that applicants follow scientific updates published in the major oncology journals, including Annals of Oncology and ESMO Open, and other educational material produced by ESMO.

The OncologyPRO Tumour Sites Portal groups ESMO resources according to the disease or the topic area and will help you find the educational material more easily.

Webcasts from the ESMO Academy 2018 can also be accessed via OncologyPRO. (ESMO members and event attendees)

Privacy Policy

No information about the participation to the ESMO Examination or the obtained results will be communicated to third parties unless authorised by the candidate and only if requested.

ESMO Examination 2018

Read the report from the 2018 ESMO Examination

Examination analysis

ESMO Examination analysis is powered by the University of Bern, Switzerland. Representatives from the Institute for Medical Education of the University of Bern have acknowledged the authority of the ESMO Examination and its value as a high-quality assessment tool.